tiprankstipranks
Trending News
More News >
Gillette India Limited (IN:GILLETTE)
:GILLETTE
India Market
Advertisement

Gillette India Limited (GILLETTE) AI Stock Analysis

Compare
3 Followers

Top Page

IN:GILLETTE

Gillette India Limited

(GILLETTE)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
₹10,846.00
▲(13.77% Upside)
The overall stock score of 66 reflects strong financial performance, which is the most significant factor. However, technical indicators suggest a bearish trend, and the high P/E ratio indicates overvaluation, which tempers the overall score.

Gillette India Limited (GILLETTE) vs. iShares MSCI India ETF (INDA)

Gillette India Limited Business Overview & Revenue Model

Company DescriptionGillette India Limited manufactures and sells grooming and oral care products in India and internationally. The company offers shaving system and cartridges, blades, toiletries, razors, and components; and toothbrushes and oral care products. It also provides female grooming products under the Gillette Venus name; and body shaving and trimming, skin care, and aftershave products. The company sells its products primarily under the Gillette and Oral-B brands. It markets and sells its products through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, and high frequency stores. Gillette India Limited was incorporated in 1984 and is based in Mumbai, India.
How the Company Makes MoneyGillette India Limited generates revenue through the sale of grooming and oral care products. The company's primary revenue stream comes from its grooming segment, which includes razors, blades, and other shaving products. These products are marketed under the Gillette brand, which has a strong brand presence and consumer loyalty. In addition to grooming products, Gillette India earns revenue from its oral care segment with products marketed under the Oral-B brand. Key factors contributing to the company's earnings include its extensive distribution network, strategic marketing campaigns, and product innovation. As a subsidiary of Procter & Gamble, Gillette India benefits from the parent company's global expertise in consumer goods and access to significant research and development resources.

Gillette India Limited Financial Statement Overview

Summary
Gillette India Limited demonstrates strong financial health with robust revenue growth, high profitability margins, and a stable balance sheet with minimal leverage. However, the decline in free cash flow growth is a concern, slightly impacting the overall financial performance score.
Income Statement
85
Very Positive
Gillette India Limited has demonstrated strong revenue growth with a 6.67% increase in the latest period. The company maintains robust profitability margins, with a gross profit margin of 50.23% and a net profit margin of 18.69%. The EBIT margin of 25.18% and EBITDA margin of 28.05% indicate efficient operational management. Overall, the income statement reflects a healthy financial performance with consistent growth and profitability.
Balance Sheet
80
Positive
The balance sheet of Gillette India Limited shows a very low debt-to-equity ratio, indicating minimal leverage and financial risk. The return on equity is impressive at 54.43%, showcasing effective use of shareholder funds to generate profits. The equity ratio is strong, reflecting a solid capital structure. Overall, the balance sheet is stable with low leverage and high returns on equity.
Cash Flow
70
Positive
The cash flow statement reveals a decline in free cash flow growth by 34.23%, which is a concern. However, the company maintains a healthy free cash flow to net income ratio of 87.39%, indicating good cash conversion. The operating cash flow to net income ratio is moderate at 44.25%. While cash flow generation is strong, the recent decline in free cash flow growth warrants attention.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue28.80B29.80B26.33B24.77B22.56B20.09B
Gross Profit16.24B14.97B14.82B9.06B8.68B11.20B
EBITDA8.07B8.36B6.54B5.61B4.90B4.87B
Net Income5.34B5.57B4.12B3.56B2.89B3.10B
Balance Sheet
Total Assets19.18B19.18B18.31B19.16B16.19B13.95B
Cash, Cash Equivalents and Short-Term Investments4.26B4.19B4.73B4.53B2.89B1.64B
Total Debt500.00K500.00K500.00K500.00K1.20M1.60M
Total Liabilities8.95B8.95B8.59B9.27B7.58B6.06B
Stockholders Equity10.23B10.23B9.71B9.89B8.61B7.89B
Cash Flow
Free Cash Flow5.25B3.02B4.42B3.84B3.45B3.53B
Operating Cash Flow5.95B3.46B5.09B4.63B4.62B4.43B
Investing Cash Flow-658.90M-435.20M-491.50M-666.70M-1.12B-793.50M
Financing Cash Flow-6.52B-3.58B-4.40B-2.31B-2.25B-4.30B

Gillette India Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price9533.60
Price Trends
50DMA
10353.79
Negative
100DMA
10056.27
Negative
200DMA
9311.75
Positive
Market Momentum
MACD
-147.25
Positive
RSI
35.14
Neutral
STOCH
4.25
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:GILLETTE, the sentiment is Negative. The current price of 9533.6 is below the 20-day moving average (MA) of 10081.80, below the 50-day MA of 10353.79, and above the 200-day MA of 9311.75, indicating a neutral trend. The MACD of -147.25 indicates Positive momentum. The RSI at 35.14 is Neutral, neither overbought nor oversold. The STOCH value of 4.25 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:GILLETTE.

Gillette India Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
₹104.17B34.6658.21%2.94%2.37%23.22%
69
Neutral
₹604.66B43.3986.32%2.29%2.12%-1.45%
66
Neutral
₹310.65B55.141.17%13.05%38.04%
65
Neutral
₹111.79B20.5313.26%1.46%2.37%-22.53%
59
Neutral
₹402.24B39.899.67%21.58%393.14%
57
Neutral
₹146.16B52.9510.18%0.09%49.07%36.05%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:GILLETTE
Gillette India Limited
9,499.85
1,163.63
13.96%
IN:COLPAL
Colgate-Palmolive (India) Limited
2,218.70
-1,515.19
-40.58%
IN:GODREJIND
Godrej Industries Limited
1,193.50
-43.30
-3.50%
IN:PGEL
PG Electroplast Limited
514.50
-128.22
-19.95%
IN:PGHL
Procter & Gamble Health Ltd.
6,302.15
1,054.33
20.09%
IN:WELSPUNLIV
Welspun Living Limited
114.70
-47.11
-29.11%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 24, 2025